Bio-Technology General Euflexxa 1% Sodium Hyaluronate

Kraj: Singapur

Język: angielski

Źródło: HSA (Health Sciences Authority)

Dostępny od:

FERRING PHARMACEUTICALS PRIVATE LIMITED

Klasa:

Class D medical device

Wyprodukowano przez:

Bio-Technology General (Israel) Ltd.

Dziedzina terapeutyczna:

Orthopaedics

Wskazania:

EUFLEXXA is indicated for the treatment of pain caused by osteoarthritis of the knee, hip, temporomandibular, carpometacarpal, shoulder and ankle joints. EUFLEXXA aids in lubrication of the joint, allows for greater mobility and flexibility of the treated joint, and reduces pain in the affected joint.

Podsumowanie produktu:

Device System Info:[Sterile Medical Device], EUFLEXXA is packed in a single-use, aseptically-filled disposable sterile 2.25 ml syringe (nominal volume) containing either 1 ml or 2 ml of 1% microbial fermentation-derived NaHA in phosphate-buffered saline; Models: Euflexxa 1% Sodium Hyaluronate - 3 x 2ml, Euflexxa 1% Sodium Hyaluronate - 1 x 2ml

Data autoryzacji:

2017-04-28